Parallelism in Immunoassay Validation: Why It Matters and How to Test for It

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Parallelism testing confirms that diluted samples produce signal responses that track the standard curve, which is required for valid quantitative immunoassay results.
• Run a dilution series of at least three to five sample dilutions alongside the standard curve, then compare the back-calculated concentrations for consistency.
• Non-parallelism indicates matrix interference or antibody affinity differences, and it means the assay cannot reliably quantify that sample type without protocol changes.

What Is Parallelism in Immunoassay Validation

Parallelism is a fundamental property of a validated immunoassay. It describes the situation where serial dilutions of a sample produce signal responses that run parallel to the standard curve when plotted on a log-log or semi-log scale. When parallelism holds, the assay measures the analyte in the sample with the same efficiency and specificity as it measures the calibrator in the standard curve. This property is the basis for the assumption that the standard curve can be used to interpolate unknown sample concentrations.

The concept is rooted in the principle of immunochemical equivalence. A standard curve is constructed using known concentrations of a purified or recombinant analyte. The antibody pair in the assay binds to the analyte in the calibrator. For the assay to be valid for unknown samples, the antibody pair must bind to the analyte in the sample matrix with the same affinity and specificity. If the sample contains the same analyte but in a different molecular form, such as a precursor, a degradation product, or a complex with binding proteins, the antibody may bind differently. This difference changes the shape of the dilution response curve, and the sample curve will not be parallel to the standard curve.

Parallelism is not a single measurement. It is a property that must be demonstrated during assay validation and rechecked when the sample matrix changes. The validation process involves preparing a dilution series from a sample with a known or measurable concentration of the analyte, measuring each dilution, and comparing the measured concentrations after correcting for the dilution factor. If the corrected concentrations are consistent across the dilution range, the assay is said to exhibit parallelism.

The importance of parallelism extends beyond the laboratory bench. In clinical diagnostics, veterinary medicine, and food safety testing, immunoassays are used to make decisions about patient care, animal health, and product release. A non-parallel sample can produce a falsely low or falsely high result, leading to incorrect decisions. For example, a sample that does not dilute in parallel may appear to have a lower concentration than it actually has, or the concentration may appear to increase with dilution, a phenomenon known as the hook effect. Both outcomes compromise the reliability of the assay.

The concept of parallelism is closely related to dilutional linearity. Dilutional linearity is the property that the measured concentration of a diluted sample, after multiplying by the dilution factor, equals the concentration of the undiluted sample. Parallelism is the graphical representation of this property. When the dilution response curve is parallel to the standard curve, the assay is dilutionally linear. When the curves diverge, the assay is not dilutionally linear, and the sample result is unreliable.

Parallelism testing is a standard component of immunoassay validation protocols. It is described in regulatory guidance documents and in laboratory method references. The National Library of Medicine provides access to authoritative laboratory-method references that describe the principles of assay validation, including parallelism testing. These references serve as a gateway to the broader literature on molecular biology and laboratory methods, and they are useful for researchers who need to understand the theoretical basis of parallelism before designing their own validation experiments.

Why Parallelism Matters for Quantitative Accuracy

The quantitative accuracy of an immunoassay depends on the assumption that the standard curve and the sample response are governed by the same relationship between concentration and signal. This assumption is tested by parallelism. When parallelism holds, the assay can be used to calculate the concentration of an unknown sample by interpolating its signal on the standard curve. When parallelism fails, the interpolation is invalid, and the calculated concentration is not trustworthy.

The underlying mechanism is the law of mass action. In a typical immunoassay, the antibody binds to the analyte to form an antibody-analyte complex. The amount of complex formed is proportional to the concentration of the analyte, but only if the antibody has the same affinity for the analyte in the sample as it does for the analyte in the calibrator. If the sample contains the analyte in a different molecular form, the antibody may bind it with a different affinity, and the amount of complex formed at a given concentration will differ from the amount formed with the calibrator.

This difference in affinity can arise from several sources. The sample may contain the analyte as a prohormone, a precursor, a fragment, or a complex with a binding protein. The antibody may recognize an epitope that is hidden in the complex or exposed only in the free form. The sample matrix may contain substances that interfere with the antibody-analyte interaction, such as heterophilic antibodies, rheumatoid factor, or high concentrations of lipids or proteins. Each of these factors can change the shape of the dilution response curve and cause non-parallelism.

The practical consequence of non-parallelism is that the assay cannot be used to quantify the analyte in that sample. The researcher or laboratory professional must either change the sample preparation, change the assay format, or use a different method. In some cases, the sample can be diluted further to reduce the interference, but this is only valid if the dilution series demonstrates parallelism at the higher dilution factors.

Parallelism is also important for the validation of multiplex assays. In a multiplex assay, multiple analytes are measured simultaneously in the same sample. Each analyte has its own standard curve, and each must be validated for parallelism. The sample matrix may affect each analyte differently, so a sample that is parallel for one analyte may not be parallel for another. The validation of a multiplex assay requires a parallelism test for each analyte.

The measurement science behind parallelism is supported by the work of the National Institute of Standards and Technology. NIST laboratory programs focus on measurement science, standards, calibration, and quality. The principles of calibration and quality control that NIST promotes are directly applicable to immunoassay validation. The standard curve is a calibration curve, and the parallelism test is a quality control check that the calibration is valid for the sample matrix.

The Standard Curve and the Dilution Series

The standard curve is the foundation of the quantitative immunoassay. It is constructed by measuring the signal from a series of calibrators with known concentrations of the analyte. The signal is plotted against the concentration, and a mathematical function is fitted to the data. The function is used to interpolate the concentration of unknown samples from their signals.

The dilution series is the tool used to test parallelism. A sample with a known concentration of the analyte is diluted in the assay buffer or in the sample matrix. The diluted samples are measured, and the measured concentrations are compared to the expected concentrations based on the dilution factor. If the measured concentrations are within an acceptable range of the expected concentrations, the assay is parallel.

The design of the dilution series is important. The series should cover the range of the standard curve, from the lower limit of quantification to the upper limit of quantification. The sample should be diluted to at least three to five different concentrations, and the dilutions should be spaced to cover the dynamic range of the assay. The sample matrix should be the same as the matrix of the samples that will be tested in the assay, because the matrix can affect the antibody-analyte interaction.

The dilution series is also used to test the hook effect. The hook effect occurs when the signal increases with concentration up to a point, then decreases at very high concentrations. This can happen when the analyte is present at a very high concentration and the antibody is saturated. The dilution series can reveal the hook effect if the measured concentrations do not increase proportionally with the dilution factor.

The standard curve and the dilution series are both plotted on the same graph. The x-axis is the concentration, and the y-axis is the signal. The standard curve is the fitted function, and the dilution series is the measured signals of the diluted samples. If the dilution series points fall on the standard curve, the assay is parallel. If the points deviate from the curve, the assay is not parallel.

The comparison of the dilution series to the standard curve can be done visually or statistically. The visual comparison is a quick check, but it is subjective. The statistical comparison is more rigorous and is preferred for validation. The statistical methods are described in the next section.

Statistical Analysis of Parallelism

The statistical analysis of parallelism is used to determine whether the dilution series responses are significantly different from the standard curve. The analysis is based on the comparison of the slopes of the two curves. If the slopes are not significantly different, the curves are parallel, and the assay is valid for the sample.

The most common statistical method is the analysis of covariance (ANCOVA). The ANCOVA compares the slopes of the standard curve and the dilution series, while controlling for the effect of the concentration. The null hypothesis is that the slopes are equal. If the p-value is greater than the significance level, the null hypothesis is not rejected, and the assay is considered parallel.

The ANCOVA requires that the data meet certain assumptions. The data should be normally distributed, and the variance should be homogeneous. The data should be transformed if necessary, such as a log transformation, to meet these assumptions. The ANCOVA is a parametric test, and it is sensitive to outliers. The data should be checked for outliers before the analysis.

Another method is the comparison of the slopes using a t-test. The slopes of the standard curve and the dilution series are estimated, and the difference between the slopes is tested. The t-test is simpler than the ANCOVA, but it does not control for the effect of the concentration. The t-test is less powerful than the ANCOVA, and it is not recommended for the validation of a new assay.

The statistical analysis should be performed using a software package that can handle the regression and the statistical tests. The software should be validated for the purpose, and the results should be documented. The documentation should include the data, the fitted curves, the slopes, the p-values, and the conclusion.

The statistical analysis is a part of the validation process. The results should be interpreted in the context of the assay. A p-value that is not significant does not guarantee that the assay is parallel. The p-value is a measure of the evidence against the null hypothesis, and it is affected by the sample size. A small sample size may not have enough power to detect a difference, and a large sample size may detect a difference that is not practically important.

The practical interpretation of the parallelism test is based on the recovery of the diluted samples. The recovery is the measured concentration divided by the expected concentration, expressed as a percentage. The recovery should be within a range of 80 to 120 percent for each dilution. If the recovery is outside this range, the assay is not parallel, and the sample result is unreliable.

The recovery is a more practical measure than the p-value. The p-value is a statistical measure, and the recovery is a clinical measure. The recovery is used to decide whether the assay is valid for the sample. The recovery is also used to decide whether the sample can be diluted to reduce the interference.

The statistical analysis is a part of the validation process, and it should be documented. The documentation should include the data, the analysis, and the interpretation. The documentation is used to support the validation of the assay and to provide evidence for the regulatory submission.

Step-by-Step Protocol for Parallelism Testing

The following protocol is a practical guide for testing parallelism in an immunoassay. The protocol is based on the principles of assay validation and the standard methods described in the literature. The protocol is intended for researchers and laboratory professionals who are familiar with the basic techniques of immunoassay.

Step 1: Prepare the Sample

The sample should be a representative sample of the matrix that will be tested in the assay. The sample should have a known concentration of the analyte, or it should be a sample that is expected to have a measurable concentration. The sample should be prepared according to the assay protocol, and it should be free of any interfering substances.

The sample should be a high-concentration sample. The concentration should be high enough that the dilution series can be prepared without the concentration falling below the lower limit of quantification. The sample should be a single sample, or it can be a pool of samples from the same matrix.

Step 2: Prepare the Dilution Series

The dilution series is prepared by diluting the sample in the assay matrix. The assay matrix is the same matrix that is used for the standard curve. The dilution series should include at least three to five dilutions. The dilutions should be spaced to cover the range of the standard curve.

The dilution factor should be consistent. A common dilution series is a two-fold dilution series, where each dilution is half the concentration of the previous dilution. The dilution series should be prepared in duplicate or triplicate to account for the variability of the assay.

Step 3: Measure the Dilution Series

The dilution series is measured using the same assay protocol as the standard curve. The signal of each dilution is measured, and the concentration is calculated using the standard curve. The measured concentration is the concentration that is read from the standard curve.

The measured concentration should be recorded for each dilution. The measured concentration is the concentration of the diluted sample, and it should be multiplied by the dilution factor to get the concentration of the original sample.

Step 4: Calculate the Recovery

The recovery is calculated for each dilution. The recovery is the measured concentration of the diluted sample, multiplied by the dilution factor, divided by the expected concentration of the original sample. The expected concentration is the concentration of the original sample, which is known from the preparation.

The recovery is expressed as a percentage. The recovery should be within 80 to 120 percent for each dilution. If the recovery is outside this range, the assay is not parallel for that dilution.

Step 5: Plot the Dilution Series and the Standard Curve

The dilution series and the standard curve are plotted on the same graph. The x-axis is the concentration, and the y-axis is the signal. The standard curve is the fitted function, and the dilution series is the measured responses.

The plot is used to visually inspect the parallelism. The dilution series points should fall on the standard curve. If the points deviate from the curve, the assay is not parallel.

Step 6: Perform the Statistical Analysis

The statistical analysis is performed to determine whether the slopes of the dilution series and the standard curve are significantly different. The ANCOVA is the recommended method. The analysis is performed using a software that can calculate the regression and the statistical tests.

The null hypothesis is that the slopes are equal. The p-value is calculated. If the p-value is less than the alpha level, the null hypothesis is rejected, and the assay is not parallel. If the p-value is greater than the alpha level, the null hypothesis is not rejected, and the assay is considered parallel.

Step 7: Interpret the Results

The results of the parallelism test are interpreted in the context of the assay. The recovery and the statistical analysis are used to decide whether the assay is valid for the sample. If the assay is parallel, the sample can be quantified using the standard curve. If the assay is not parallel, the sample cannot be quantified, and the assay protocol must be changed.

The interpretation should be documented. The documentation should include the data, the analysis, and the conclusion. The documentation is used to support the validation of the assay.

Troubleshooting Non-Parallelism

Non-parallelism is a common problem in immunoassay validation. The problem can be caused by a variety of factors, and the troubleshooting process is a systematic approach to identify the cause and to correct the problem.

Matrix Interference

The most common cause of non-parallelism is matrix interference. The sample matrix contains substances that interfere with the antibody-analyte interaction. The interference can be caused by heterophilic antibodies, rheumatoid factor, or high-binding proteins. The interference can be reduced by diluting the sample, but the dilution must be parallel.

The troubleshooting is to test the sample in a different matrix. The sample can be diluted in a buffer that is free of the interfering substances. The dilution series is prepared in the buffer, and the parallelism is tested. If the parallelism is improved, the interference is caused by the matrix.

Antibody Affinity Differences

The non-parallelism can be caused by the antibody affinity differences. The antibody may have a different affinity for the analyte in the sample than for the analyte in the calibrator. The difference can be caused by the molecular form of the analyte, such as a precursor or a fragment.

The troubleshooting is to use a different antibody or a different assay format. The antibody can be changed to one that recognizes the same epitope in the sample and the calibrator. The assay format can be changed to a sandwich assay or a competitive assay.

Hook Effect

The hook effect is a cause of non-parallelism. The hook effect occurs when the signal increases with the concentration, then decreases at very high concentrations. The hook effect is caused by the saturation of the antibody.

The troubleshooting is to dilute the sample to a concentration that is within the range of the standard curve. The dilution series is tested, and the parallelism is measured. If the parallelism is improved at the lower concentrations, the hook effect is the cause.

The Standard Curve

The non-parallelism can be caused by the standard curve. The standard curve may not be a good fit to the data, or the standard curve may be constructed with a calibrator that is not representative of the sample.

The troubleshooting is to check the standard curve. The standard curve should be a good fit to the data, and the calibrator should be representative of the sample. The standard curve can be reconstructed with a different calibrator.

The Assay Protocol

The non-parallelism can be caused by the assay protocol. The protocol may have a step that is not optimized, such as the incubation time or the wash step. The protocol can be changed to improve the parallelism.

The troubleshooting is to check the assay protocol. The protocol should be followed exactly, and the steps should be optimized. The incubation time and the wash step can be changed to improve the parallelism.

Common Failure Patterns in Parallelism Testing

The parallelism testing can fail in several ways. The failure patterns are the common ways that the parallelism test does not produce a valid result. The failure patterns are useful for troubleshooting and for the interpretation of the results.

The Dilution Series Is Not Linear

The dilution series is not linear when the measured concentrations do not increase proportionally with the dilution factor. The recovery is not within the 80 to 120 percent range. The non-linearity can be caused by the matrix interference or the antibody affinity differences.

The failure pattern is identified by the plot of the dilution series. The plot is not a straight line, or the points do not fall on the standard curve. The failure pattern is corrected by the troubleshooting steps.

The Dilution Series Is Parallel but the Recovery Is Not

The dilution series is parallel to the standard curve, but the recovery is not within the acceptable range. The recovery is the measured concentration of the original sample, and it is not equal to the expected concentration. The recovery can be too high or too low.

The failure pattern is caused by a systematic error in the assay. The error can be in the preparation of the sample, the preparation of the standard curve, or the calculation of the concentration. The failure pattern is corrected by checking the assay protocol.

The Dilution Series Is Not Parallel at the High Concentrations

The dilution series is parallel at the low concentrations, but not at the high concentrations. The failure pattern is caused by the hook effect or the saturation of the antibody. The failure pattern is corrected by diluting the sample to a lower concentration.

The Dilution Series Is Not Parallel at the Low Concentrations

The dilution series is parallel at the high concentrations, but not at the low concentrations. The failure pattern is caused by the lower limit of quantification of the assay. The failure pattern is corrected by using a more sensitive assay or by concentrating the sample.

The Dilution Series Is Not Parallel in a Single Sample

The dilution series is parallel in most samples, but not in a single sample. The failure pattern is caused by the specific matrix of the sample. The failure pattern is corrected by the troubleshooting described in the previous section.

The Role of the Matrix in Parallelism

The matrix is the environment in which the analyte is measured. The matrix can be serum, plasma, urine, saliva, or a cell culture medium. The matrix can affect the antibody-analyte interaction, and it can cause non-parallelism.

The matrix effect is the difference between the response of the analyte in the matrix and the response of the analyte in the buffer. The matrix effect can be caused by the substances in the matrix, such as proteins, lipids, or salts. The matrix effect can be reduced by diluting the sample or by using a matrix that is similar to the sample.

The matrix effect is a common cause of non-parallelism. The matrix effect is tested by the parallelism test. The parallelism test is performed using the sample matrix, and the result is compared to the standard curve. If the matrix effect is present, the parallelism test will fail.

The matrix effect can be corrected by the use of a matrix-matched standard curve. The standard curve is prepared in the same matrix as the sample. The matrix-matched standard curve is used to calculate the concentration of the sample. The matrix-matched standard curve is a valid method for the correction of the matrix effect.

The matrix effect can also be corrected by the use of a surrogate matrix. The surrogate matrix is a matrix that is similar to the sample matrix but is free of the interfering substances. The surrogate matrix is used to prepare the standard curve, and the sample is diluted in the surrogate matrix.

The matrix effect is a complex issue, and the correction is not always possible. The matrix effect is a limitation of the immunoassay, and it must be considered in the validation.

The Use of the MIQE Guidelines for Parallelism

The MIQE guidelines are the Minimum Information for Publication of Quantitative Real-Time PCR Experiments. The guidelines are a set of standards for the reporting of qPCR experiments. The guidelines are relevant to the parallelism testing because they provide a framework for the reporting of the validation.

The MIQE guidelines are published in Clinical Chemistry, and they are a standard for the reporting of qPCR experiments. The guidelines are used to ensure that the experiments are reproducible and that the results are comparable. The guidelines are a source of the validation of the assay.

The MIQE guidelines are relevant to the parallelism testing because they require the reporting of the validation of the assay. The guidelines require the reporting of the standard curve, the dilution series, and the statistical analysis. The guidelines are used to ensure that the validation is complete and that the results are reliable.

The MIQE guidelines are a source of the quality for the validation. The guidelines are used to ensure that the validation is performed in a standard way and that the results are comparable. The guidelines are a valid reference for the parallelism testing.

The Use of the NIST Standards for Parallelism

The NIST standards are the standards of the National Institute of Standards and Technology. The standards are used to ensure the quality of the measurements. The standards are relevant to the parallelism testing because they provide a framework for the calibration and the quality control.

The NIST laboratory programs focus on measurement science, standards, calibration, and quality context. The programs are used to ensure the accuracy and the precision of the measurements. The programs are relevant to the validation of the immunoassay.

The NIST standards are used to ensure the quality of the standard curve. The standard curve is a calibration curve, and the calibration is a part of the measurement science. The NIST standards are used to ensure that the calibration is valid and that the measurements are accurate.

The NIST standards are also used to ensure the quality of the parallelism test. The parallelism test is a quality control, and the quality control is a part of the NIST standards. The NIST standards are used to ensure that the parallelism test is valid and that the results are reliable.

The Use of the Addgene Protocols for Parallelism

The Addgene protocols are a collection of protocols for the molecular biology. The protocols are used for the planning of the experiments. The protocols are relevant to the parallelism testing because they provide a framework for the practical planning of the validation.

The Addgene protocols are a valid reference for the molecular biology. The protocols are used to ensure that the experiments are planned in a standard manner. The protocols are relevant to the validation of the immunoassay.

The Addgene protocols are used to plan the validation. The protocols are used to plan the dilution series, the standard curve, and the statistical analysis. The protocols are used to ensure that the validation is planned in a standard manner.

The Addgene protocols are a valid reference for the planning of the validation. The protocols are used to ensure that the validation is planned in a standard manner and that the results are reliable.

The Use of the NIH Guidelines for Parallelism

The NIH guidelines are the guidelines for the research involving the recombinant or synthetic nucleic acid molecules. The guidelines are relevant to the parallelism testing because they provide a framework for the oversight of the research.

The NIH guidelines are published by the National Institutes of Health. The guidelines are used to ensure the safety of the research. The guidelines are relevant to the validation of the immunoassay if the assay uses the recombinant or synthetic nucleic acid molecules.

The NIH guidelines are used to ensure the oversight of the research. The guidelines are used to ensure that the research is conducted in a safe manner. The guidelines are relevant to the validation of the immunoassay if the assay uses the recombinant or synthetic nucleic acid molecules.

The NIH guidelines are a valid reference for the oversight of the research. The guidelines are used to ensure that the research is conducted in a safe manner and that the results are reliable.

The Use of the CDC Biosafety Guidelines for Parallelism

The CDC biosafety guidelines are the guidelines for the biosafety in the microbiological and biomedical laboratories. The guidelines are relevant to the parallelism testing because they provide a framework for the biosafety of the laboratory.

The CDC guidelines are used to ensure the biosafety of the laboratory. The guidelines are used for the risk assessment and the containment. The guidelines are relevant to the validation of the immunoassay if the assay uses the biological samples.

The CDC guidelines are used to ensure the biosafety of the laboratory. The guidelines are used to ensure that the laboratory is safe for the researchers and the environment. The guidelines are relevant to the validation of the immunoassay if the assay uses the biological samples.

The CDC guidelines are a valid reference for the biosafety of the laboratory. The guidelines are used to ensure that the laboratory is safe and that the results are reliable.

The Use of the NCBI Books for Parallelism

The NCBI books are the books of the National Library of Medicine. The books are a gateway to the authoritative laboratory-method and molecular-biology references. The books are relevant to the parallelism testing because they provide a framework for the laboratory methods.

The NCBI books are used to access the authoritative references. The books are used for the laboratory methods and the molecular biology. The books are relevant to the validation of the immunoassay.

The NCBI books are a valid reference for the laboratory methods. The books are used to access the authoritative references for the validation of the immunoassay. The books are relevant to the parallelism testing.

The NCBI books are a valid reference for the validation of the immunoassay. The books are used to access the authoritative references for the validation of the immunoassay. The books are relevant to the parallelism testing.

At a Glance

Common Failure Patterns and Corrective Actions

Workflow for Parallelism Testing

flowchart TD
    A[Prepare the sample] --> B[Prepare the dilution series]
    B --> C[Measure the dilution series]
    C --> D[Calculate the recovery]
    D --> E{Is the recovery within 80 to 120 percent?}
    E -->|Yes| F[Plot the dilution series and the standard curve]
    E -->|No| G[Troubleshoot the matrix or the antibody]
    F --> H{Are the curves parallel?}
    H -->|Yes| I[The assay is valid for the sample]
    H -->|No| G
    G --> B

Records and Measurements

The records of the parallelism test are the data and the analysis. The records are used to support the validation of the assay. The records should include the following:

• The sample identification and the matrix
• The dilution series and the dilution factors
• The measured signal and the calculated concentration for each dilution
• The recovery for each dilution
• The plot of the dilution series and the standard curve
• The statistical analysis and the p-value
• The conclusion of the parallelism test

The records should be stored in a laboratory notebook or an electronic system. The records should be dated and signed. The records should be available for the review.

The measurements of the parallelism test are the signal and the concentration. The signal is the raw response of the assay, and the concentration is the calculated value. The measurements should be recorded with the appropriate units and the number of significant figures.

The measurements should be checked for the accuracy and the precision. The accuracy is the closeness of the measured value to the true value, and the precision is the closeness of the repeated measurements. The accuracy and the precision should be within the acceptable range for the assay.

Quality Controls

The quality controls are the checks that are used to ensure the quality of the assay. The quality controls are the standard curve, the dilution series, and the statistical analysis. The quality controls are used to ensure that the assay is valid and the results are reliable.

The standard curve is a quality control. The standard curve is used to ensure that the assay is calibrated. The standard curve should be a good fit to the data, and the calibrators should be valid.

The dilution series is a quality control. The dilution series is used to ensure that the assay is parallel. The dilution series should be linear, and the recovery should be within the acceptable range.

The statistical analysis is a quality control. The statistical analysis is used to ensure that the parallelism is statistically valid. The statistical analysis should be performed using the appropriate method, and the p-value should be interpreted in the context of the assay.

The quality controls are a part of the validation. The quality controls are used to ensure that the assay is valid and the results are reliable. The quality controls are documented in the validation report.

Limitations of the Parallelism Test

The parallelism test has limitations. The limitations are the conditions under which the test is not valid. The limitations are important to consider when the test is used.

The parallelism test is limited by the sample size. The test is performed on a single sample or a pool of samples. The test is not a guarantee that the assay is parallel for all samples. The test is a check of the assay for the specific sample.

The parallelism test is limited by the dilution range. The test is performed over a range of dilutions. The test is not valid for the concentrations outside the range. The test is a check of the assay for the specific range.

The parallelism test is limited by the statistical power. The test is a statistical test, and the power is the ability to detect a difference. The power is affected by the sample size and the variability. The test may not detect a difference that is small.

The parallelism test is limited by the matrix. The test is performed in a specific matrix. The test is not valid for the other matrices. The test is a check of the assay for the specific matrix.

The limitations of the parallelism test are important to consider. The limitations are used to interpret the results and to decide whether the assay is valid for the sample.

Professional Escalation Criteria

The professional escalation criteria are the criteria for the escalation of the issue to a professional. The criteria are used when the parallelism test fails and the issue cannot be resolved by the troubleshooting.

The escalation criteria are the following:

• The parallelism test fails, and the troubleshooting does not resolve the issue.
• The parallelism test fails, and the issue is caused by the matrix that cannot be changed.
• The parallelism test fails, and the issue is caused by the antibody that cannot be changed.
• The parallelism test fails, and the issue is caused by the standard curve that cannot be changed.

The escalation is to a professional who is experienced in the immunoassay validation. The professional can be a senior researcher, a laboratory manager, or a consultant. The professional can review the data and the analysis and provide the guidance.

The escalation is a valid step in the validation. The escalation is used to ensure that the issue is resolved and the assay is valid. The escalation is documented in the validation report.

Frequently Asked Questions

What is the difference between parallelism and dilutional linearity?

Parallelism is the visual relationship between the dilution series and the standard curve. Dilutional linearity is the quantitative relationship between the measured concentration and the dilution factor. Parallelism is the visual check, and dilutional linearity is the quantitative check. Both are used to validate the assay.

How many dilutions are needed for a parallelism test?

The number of dilutions depends on the range of the standard curve. A minimum of three to five dilutions is recommended. The dilutions should be spaced to cover the range of the standard curve. The dilutions should be prepared in duplicate or triplicate.

What is the acceptable recovery for a parallelism test?

The acceptable recovery is 80 to 120 percent. The recovery is the measured concentration of the original sample, divided by the expected concentration. The recovery is calculated for each dilution. The recovery should be within the acceptable range for each dilution.

What is the hook effect in an immunoassay?

The hook effect is the decrease in the signal at very high concentrations. The hook effect is caused by the saturation of the antibody. The hook effect can cause a falsely low concentration. The hook effect is detected by the dilution series.

What is the matrix effect in an immunoassay?

The matrix effect is the effect of the sample matrix on the antibody-analyte interaction. The matrix effect is caused by the substances in the matrix. The matrix effect can cause non-parallelism. The matrix effect is corrected by the use of a matrix-matched standard curve.

What is the ANCOVA test for parallelism?

The ANCOVA test is the analysis of covariance. The ANCOVA test is used to compare the slopes of the standard curve and the dilution series. The ANCOVA test is the recommended method for the statistical analysis of parallelism.

What is the role of the standard curve in the parallelism test?

The standard curve is the calibration curve of the assay. The standard curve is used to calculate the concentration of the sample. The standard curve is the reference for the parallelism test. The dilution series is compared to the standard curve.

What is the role of the matrix in the parallelism test?

The matrix is the environment in which the analyte is measured. The matrix can affect the antibody-analyte interaction. The matrix is used to prepare the dilution series and the standard curve. The matrix is a valid factor in the parallelism test.

Related Molecular Biology Guides

• Western Blot Test: How It Works and What It Detects
• mRNA Stability: What It Is and Why It Matters
• DNA Melting Temperature: What It Is and Why It Matters
• RNA Modification: Types, Steps, and Why It Matters
• Why Protein Quantification Is Important in Biological Research

References and Further Reading

• Molecular Biology and Laboratory Methods. National Library of Medicine.
• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
• Addgene Protocols. Addgene.
• MIQE Guidelines. Clinical Chemistry.
• NIST Laboratory Programs. National Institute of Standards and Technology.
• Statistical correction for non-parallelism in a urinary enzyme immunoassay.. Journal of immunoassay & immunochemistry, 2004.
• Enzyme immunoassay techniques. An overview.. Journal of immunological methods, 1992.
• Miniaturised multiplexed immunoassays.. Current opinion in chemical biology, 2002.
• Measuring parallelism, linearity, and relative potency in bioassay and immunoassay data.. Journal of biopharmaceutical statistics, 2005.
• DNA-Encoded Immunoassay in Picoliter Drops: A Minimal Cell-Free Approach.. Advanced biology, 2023.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.